Marks Group Wealth Management Inc Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Marks Group Wealth Management Inc decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,756 shares of the medical equipment provider's stock after selling 1,353 shares during the quarter. Marks Group Wealth Management Inc's holdings in Intuitive Surgical were worth $4,832,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Chilton Capital Management LLC grew its stake in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. Global Financial Private Client LLC grew its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Finally, Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter worth approximately $26,000. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. BTIG Research set a $566.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Finally, Citigroup reissued a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $592.86.

Insider Transactions at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 0.1%

Shares of ISRG traded up $0.41 during midday trading on Wednesday, hitting $512.64. 1,863,510 shares of the company's stock traded hands, compared to its average volume of 1,685,801. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The firm's fifty day moving average is $537.18 and its 200-day moving average is $536.37. The stock has a market capitalization of $183.74 billion, a price-to-earnings ratio of 75.17, a price-to-earnings-growth ratio of 5.43 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business posted $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.